11/7
09:00 am
chrs
Coherus Oncology Presents at SITC Clinical Multiomic Biomarker Data for CHS-114, a Highly Selective anti-CCR8 Cytolytic Antibody
Low
Report
Coherus Oncology Presents at SITC Clinical Multiomic Biomarker Data for CHS-114, a Highly Selective anti-CCR8 Cytolytic Antibody
11/6
04:14 pm
chrs
Coherus Oncology Reports Third Quarter 2025 Financial Results and Provides Business Update
Medium
Report
Coherus Oncology Reports Third Quarter 2025 Financial Results and Provides Business Update
11/6
01:54 pm
chrs
Arvind Sood joins Coherus Oncology as Chief Strategy and Corporate Affairs Officer
Low
Report
Arvind Sood joins Coherus Oncology as Chief Strategy and Corporate Affairs Officer
10/30
08:30 am
chrs
Coherus Oncology to Report Third Quarter 2025 Financial Results on November 6, 2025
Low
Report
Coherus Oncology to Report Third Quarter 2025 Financial Results on November 6, 2025
10/23
08:30 am
chrs
Coherus Oncology to Participate in Upcoming Investor Conferences
Medium
Report
Coherus Oncology to Participate in Upcoming Investor Conferences
10/3
09:05 am
chrs
Coherus Oncology Announces Poster Presentation at the 40th Annual Meeting of the Society for Immunotherapy of Cancer (SITC)
Low
Report
Coherus Oncology Announces Poster Presentation at the 40th Annual Meeting of the Society for Immunotherapy of Cancer (SITC)